A Comparative Study of the Target Orientated Algorithm and the Trial and Error Method in the Regional Citrate Anticoagulation for Continuous Veno-Venous Hemodialysis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029528

Enrollment

Unknown

Registered

2020-02-03

Start date

2020-02-15

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

regional sodium citrate anticoagulation

Interventions

TOA-CVVHD group:Target orientated algorithm

TE-CVVHDF group:Trial and error method

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Indications for renal replacement therapy (RRT); 3. The patient is fit to use CVVHD.

Exclusion criteria

Exclusion criteria: 1. Severe liver dysfunction; 2. Pregnant woman; 3. Contraindication for sodium citrate anticoagulation.

Design outcomes

Primary

Measure	Time frame
Numbers of serum iCa exceeding the allowable range;	—

Secondary

Measure	Time frame
Serum ion calcium;Ion calcium after filter;Serum calcium;calcium balance;	—

Countries

China

Contacts

Public ContactWang Xuemin

Shanghai Songjiang District Central Hospital

wangxm100@hotmail.com+86 18918285282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026